Current Winner
2012 Innovation Challenge Award

Scott Fitzpatrick

Minimally Invasive Posterior Segment Therapeutics

Scott Fitzpatrick

Scott Fitzpatrick developed a minimally invasive drug delivery method for numerous conditions that affect the back of the eye and threaten vision. This treatment has the potential to increase drug efficacy, decrease unwanted side effects, improve patient compliance and allow for ease of use.